Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension
Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we ana...
Gespeichert in:
Veröffentlicht in: | Interventional neurology 2020-01, Vol.8 (2-6), p.164-171 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 171 |
---|---|
container_issue | 2-6 |
container_start_page | 164 |
container_title | Interventional neurology |
container_volume | 8 |
creator | Al-Mufti, Fawaz Dodson, Vincent Amuluru, Krishna Walia, Jessy Wajswol, Ethan Nuoman, Rolla Keller, Irwin A. Schonfeld, Steven Roychowdhury, Sudipta Gupta, Gaurav |
description | Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy. |
doi_str_mv | 10.1159/000500051 |
format | Article |
fullrecord | <record><control><sourceid>pubmed_karge</sourceid><recordid>TN_cdi_karger_primary_500051</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>32508898</sourcerecordid><originalsourceid>FETCH-LOGICAL-c424t-2e85457cf10321f396ec0b5526ac86b02e549ee14ae42624c7fd051681efd62b3</originalsourceid><addsrcrecordid>eNpt0EFLwzAUB_AgihtzB-8iBU8eqkmapO1FkDFdQSYyPZc0fd2iXVrSdrBvb0ZnUfAQEsgv__fyELok-I4QHt9jjPlhkRM0JkIwn3PGT4_nOAzCEZo2zacjWMQhZuwcjQLKcRTF0Ri9LaGzFZi82slGdaW03gwsZFaW3kqbrvFWLZhWm7WnjZfkuqplu9HKS0xrpbLSaCcX-xqsc42uzAU6K2TZwPS4T9DH0_x9tvBfXp-T2eOLrxhlrU8hcn2GqiA4oKQIYgEKZ5xTIVUkMkyBsxiAMAmMCspUWOTukyIiUOSCZsEEPfS5dZdtIVdwaKhMa6u30u7TSur0743Rm3Rd7dKQ8iAS1AXc9gHKVk1joRjeEpweRpsOo3X2-nexQf4M0oGbHnxJuwY7gGQ57yPSOi-cuvpXHat8Az6pii0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension</title><source>PubMed Central</source><creator>Al-Mufti, Fawaz ; Dodson, Vincent ; Amuluru, Krishna ; Walia, Jessy ; Wajswol, Ethan ; Nuoman, Rolla ; Keller, Irwin A. ; Schonfeld, Steven ; Roychowdhury, Sudipta ; Gupta, Gaurav</creator><creatorcontrib>Al-Mufti, Fawaz ; Dodson, Vincent ; Amuluru, Krishna ; Walia, Jessy ; Wajswol, Ethan ; Nuoman, Rolla ; Keller, Irwin A. ; Schonfeld, Steven ; Roychowdhury, Sudipta ; Gupta, Gaurav</creatorcontrib><description>Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.</description><identifier>ISSN: 1664-9737</identifier><identifier>EISSN: 1664-5545</identifier><identifier>DOI: 10.1159/000500051</identifier><identifier>PMID: 32508898</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Review</subject><ispartof>Interventional neurology, 2020-01, Vol.8 (2-6), p.164-171</ispartof><rights>2019 S. Karger AG, Basel</rights><rights>Copyright © 2019 by S. Karger AG, Basel.</rights><rights>Copyright © 2019 by S. Karger AG, Basel 2019</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c424t-2e85457cf10321f396ec0b5526ac86b02e549ee14ae42624c7fd051681efd62b3</citedby><cites>FETCH-LOGICAL-c424t-2e85457cf10321f396ec0b5526ac86b02e549ee14ae42624c7fd051681efd62b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253862/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253862/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32508898$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al-Mufti, Fawaz</creatorcontrib><creatorcontrib>Dodson, Vincent</creatorcontrib><creatorcontrib>Amuluru, Krishna</creatorcontrib><creatorcontrib>Walia, Jessy</creatorcontrib><creatorcontrib>Wajswol, Ethan</creatorcontrib><creatorcontrib>Nuoman, Rolla</creatorcontrib><creatorcontrib>Keller, Irwin A.</creatorcontrib><creatorcontrib>Schonfeld, Steven</creatorcontrib><creatorcontrib>Roychowdhury, Sudipta</creatorcontrib><creatorcontrib>Gupta, Gaurav</creatorcontrib><title>Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension</title><title>Interventional neurology</title><addtitle>Intervent Neurol</addtitle><description>Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.</description><subject>Review</subject><issn>1664-9737</issn><issn>1664-5545</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpt0EFLwzAUB_AgihtzB-8iBU8eqkmapO1FkDFdQSYyPZc0fd2iXVrSdrBvb0ZnUfAQEsgv__fyELok-I4QHt9jjPlhkRM0JkIwn3PGT4_nOAzCEZo2zacjWMQhZuwcjQLKcRTF0Ri9LaGzFZi82slGdaW03gwsZFaW3kqbrvFWLZhWm7WnjZfkuqplu9HKS0xrpbLSaCcX-xqsc42uzAU6K2TZwPS4T9DH0_x9tvBfXp-T2eOLrxhlrU8hcn2GqiA4oKQIYgEKZ5xTIVUkMkyBsxiAMAmMCspUWOTukyIiUOSCZsEEPfS5dZdtIVdwaKhMa6u30u7TSur0743Rm3Rd7dKQ8iAS1AXc9gHKVk1joRjeEpweRpsOo3X2-nexQf4M0oGbHnxJuwY7gGQ57yPSOi-cuvpXHat8Az6pii0</recordid><startdate>20200101</startdate><enddate>20200101</enddate><creator>Al-Mufti, Fawaz</creator><creator>Dodson, Vincent</creator><creator>Amuluru, Krishna</creator><creator>Walia, Jessy</creator><creator>Wajswol, Ethan</creator><creator>Nuoman, Rolla</creator><creator>Keller, Irwin A.</creator><creator>Schonfeld, Steven</creator><creator>Roychowdhury, Sudipta</creator><creator>Gupta, Gaurav</creator><general>S. Karger AG</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20200101</creationdate><title>Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension</title><author>Al-Mufti, Fawaz ; Dodson, Vincent ; Amuluru, Krishna ; Walia, Jessy ; Wajswol, Ethan ; Nuoman, Rolla ; Keller, Irwin A. ; Schonfeld, Steven ; Roychowdhury, Sudipta ; Gupta, Gaurav</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c424t-2e85457cf10321f396ec0b5526ac86b02e549ee14ae42624c7fd051681efd62b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al-Mufti, Fawaz</creatorcontrib><creatorcontrib>Dodson, Vincent</creatorcontrib><creatorcontrib>Amuluru, Krishna</creatorcontrib><creatorcontrib>Walia, Jessy</creatorcontrib><creatorcontrib>Wajswol, Ethan</creatorcontrib><creatorcontrib>Nuoman, Rolla</creatorcontrib><creatorcontrib>Keller, Irwin A.</creatorcontrib><creatorcontrib>Schonfeld, Steven</creatorcontrib><creatorcontrib>Roychowdhury, Sudipta</creatorcontrib><creatorcontrib>Gupta, Gaurav</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Interventional neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al-Mufti, Fawaz</au><au>Dodson, Vincent</au><au>Amuluru, Krishna</au><au>Walia, Jessy</au><au>Wajswol, Ethan</au><au>Nuoman, Rolla</au><au>Keller, Irwin A.</au><au>Schonfeld, Steven</au><au>Roychowdhury, Sudipta</au><au>Gupta, Gaurav</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension</atitle><jtitle>Interventional neurology</jtitle><addtitle>Intervent Neurol</addtitle><date>2020-01-01</date><risdate>2020</risdate><volume>8</volume><issue>2-6</issue><spage>164</spage><epage>171</epage><pages>164-171</pages><issn>1664-9737</issn><eissn>1664-5545</eissn><abstract>Idiopathic intracranial hypertension (IIH) is a rare, ill-understood disease of significant morbidity. Because the pathophysiology is poorly understood, treatment protocols are not uniform and are directed towards alleviating the most common symptoms: headache and visual loss. In this review, we analyze 25 case series, all of which included IIH patients (n = 408) who were treated with placement of a venous sinus stent. Among 342 patients who had headache, 240 patients (70.2%) had improvement or resolution of headache after the stent insertion. Of the 217 patients documented to have visual problems, visual acuity was improved or stabilized in 161 patients (74.2%). Of the 304 patients with papilledema, 257 showed resolution or improved (84.5%). Of the 124 patients who presented with pulsatile tinnitus, it was resolved in 110 patients (88.7%) after stent placement. Endovascular management of dural sinus stenosis is therefore clinically efficacious in patients with IIH who have failed medical and surgical therapy.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>32508898</pmid><doi>10.1159/000500051</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-9737 |
ispartof | Interventional neurology, 2020-01, Vol.8 (2-6), p.164-171 |
issn | 1664-9737 1664-5545 |
language | eng |
recordid | cdi_karger_primary_500051 |
source | PubMed Central |
subjects | Review |
title | Neuroendovascular Cerebral Sinus Stenting in Idiopathic Intracranial Hypertension |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T05%3A27%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroendovascular%20Cerebral%20Sinus%20Stenting%20in%20Idiopathic%20Intracranial%20Hypertension&rft.jtitle=Interventional%20neurology&rft.au=Al-Mufti,%20Fawaz&rft.date=2020-01-01&rft.volume=8&rft.issue=2-6&rft.spage=164&rft.epage=171&rft.pages=164-171&rft.issn=1664-9737&rft.eissn=1664-5545&rft_id=info:doi/10.1159/000500051&rft_dat=%3Cpubmed_karge%3E32508898%3C/pubmed_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/32508898&rfr_iscdi=true |